Track Better Therapeutics's common stock ($4K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
Better Therapeutics (BTTX) currently reports a common stock of $4K as of September 2023. That compares with $2K in the prior-year period — up 100.0% year over year. Use the charts on this page to explore Better Therapeutics's common stock history and peer comparisons.
Better Therapeutics's common stock increased from $2K to $4K — a 100.0% year-over-year increase (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Better Therapeutics reported $4K in common stock as of September 2023. That compares with $2K in the prior-year period — up 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $4K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Better Therapeutics, and consider following BTTX for alerts when major investors trade the stock.